FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1557-1565 November 14, 2002 Number 20 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Mosca, L. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Both C-reactive protein and low-density lipoprotein (LDL) cholesterol levels are elevated in persons at risk for cardiovascular events. However, population-based data directly comparing these two biologic markers are not available.

Methods C-reactive protein and LDL cholesterol were measured at base line in 27,939 apparently healthy American women, who were then followed for a mean of eight years for the occurrence of myocardial infarction, ischemic stroke, coronary revascularization, or death from cardiovascular causes. We assessed the value of these two measurements in predicting the risk of cardiovascular events in the study population.

Results Although C-reactive protein and LDL cholesterol were minimally correlated (r=0.08), base-line levels of each had a strong linear relation with the incidence of cardiovascular events. After adjustment for age, smoking status, the presence or absence of diabetes mellitus, categorical levels of blood pressure, and use or nonuse of hormone-replacement therapy, the relative risks of first cardiovascular events according to increasing quintiles of C-reactive protein, as compared with the women in the lowest quintile, were 1.4, 1.6, 2.0, and 2.3 (P<0.001), whereas the corresponding relative risks in increasing quintiles of LDL cholesterol, as compared with the lowest, were 0.9, 1.1, 1.3, and 1.5 (P<0.001). Similar effects were observed in separate analyses of each component of the composite end point and among users and nonusers of hormone-replacement therapy. Overall, 77 percent of all events occurred among women with LDL cholesterol levels below 160 mg per deciliter (4.14 mmol per liter), and 46 percent occurred among those with LDL cholesterol levels below 130 mg per deciliter (3.36 mmol per liter). By contrast, because C-reactive protein and LDL cholesterol measurements tended to identify different high-risk groups, screening for both biologic markers provided better prognostic information than screening for either alone. Independent effects were also observed for C-reactive protein in analyses adjusted for all components of the Framingham risk score.

Conclusions These data suggest that the C-reactive protein level is a stronger predictor of cardiovascular events than the LDL cholesterol level and that it adds prognostic information to that conveyed by the Framingham risk score.

Source Information

From the Center for Cardiovascular Disease Prevention and the Divisions of Preventive Medicine (P.M.R., L.R., J.E.B., N.R.C.) and Cardiology (P.M.R.), Brigham and Women's Hospital and Harvard Medical School; and the Department of Laboratory Medicine, Children's Hospital and Harvard Medical School (N.R.) — all in Boston.

Address reprint requests to Dr. Ridker at the Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, 900 Commonwealth Ave. East, Boston, MA 02215, or at pridker{at}partners.org.

Full Text of this Article

Related Letters:

C-Reactive Protein in the Prediction of Cardiovascular Events
Lloyd-Jones D. M., Levy D., Brezis M., Evans M. K., Zonderman A. B., Johnson W. R., Ridker P. M., Buring J. E., Cook N. R.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1059-1061, Mar 13, 2003. Correspondence

This article has been cited by other articles:

• Lund, S. S, Tarnow, L., Stehouwer, C. D A, Schalkwijk, C. G, Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U. M, Pedersen, O., Parving, H.-H., Vaag, A. A (2008). Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol 158: 631-641 [Abstract] [Full Text]  
• Nagaoka, T., Kuo, L., Ren, Y., Yoshida, A., Hein, T. W. (2008). C-Reactive Protein Inhibits Endothelium-Dependent Nitric Oxide-Mediated Dilation of Retinal Arterioles via Enhanced Superoxide Production. IOVS 49: 2053-2060 [Abstract] [Full Text]  
• Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., Make, B. J. (2008). Comorbidities in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 549-555 [Abstract] [Full Text]  
• Caymaz, H. O., Yuksel, G. (2008). Fate of Incidental, Asymptomatic Lesions Discovered During Percutaneous Coronary Intervention. ANGIOLOGY 59: 193-197 [Abstract]  
• Shen, J., Arnett, D. K., Parnell, L. D., Peacock, J. M., Lai, C.-Q., Hixson, J. E., Tsai, M. Y., Province, M. A., Straka, R. J., Ordovas, J. M. (2008). Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response: The GOLDN Study. Diabetes Care 31: 910-915 [Abstract] [Full Text]  
• Patel, P. D., Arora, R. R. (2008). Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease. Therapeutic Advances in Cardiovascular Disease 2: 89-100 [Abstract]  
• Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., Vaccarino, V., Reis, S. E., Bittner, V., Hodgson, T. K., Rogers, W., Pepine, C. J. (2008). Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health--National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation. J. Clin. Endocrinol. Metab. 93: 1276-1284 [Abstract] [Full Text]  
• Anuurad, E., Rubin, J., Chiem, A., Tracy, R. P., Pearson, T. A., Berglund, L. (2008). High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans. J. Clin. Endocrinol. Metab. 93: 1482-1488 [Abstract] [Full Text]  
• Currie, C J, Poole, C D, Conway, P (2008). Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94: 457-462 [Abstract] [Full Text]  
• Ramaraj, R. (2008). Gender Differences Between High-Sensitivity C-Reactive Protein and Intima Media Thickness Progression. Stroke 39: e73-e73 [Full Text]  
• Clarke, R., Emberson, J. R., Breeze, E., Casas, J. P., Parish, S., Hingorani, A. D., Fletcher, A., Collins, R., Smeeth, L. (2008). Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 29: 800-809 [Abstract] [Full Text]  
• King, D. E., Mainous, A. G. III, Egan, B. M., Woolson, R. F., Geesey, M. E. (2008). Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM). Ann Fam Med 6: 100-106 [Abstract] [Full Text]  
• Conen, D, Everett, B M, Glynn, R J, Ridker, P M (2008). Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart 94: e13-e13 [Abstract] [Full Text]  
• Lau, K-K, Chan, Y-H, Yiu, K-H, Tam, S, Li, S-W, Lau, C-P, Tse, H-F (2008). Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk. Postgrad. Med. J. 84: 153-157 [Abstract] [Full Text]  
• Gozal, D., Kheirandish-Gozal, L. (2008). Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More. Am. J. Respir. Crit. Care Med. 177: 369-375 [Abstract] [Full Text]  
• Pitt, B. (2008). N-terminal pro-B-type natriuretic peptide concentrations >=100 ng/l increased risk of all-cause mortality. Evid. Based Med. 13: 26-26 [Full Text]  
• Telles, R., Lanna, C., Ferreira, G., Souza, A., Navarro, T., Ribeiro, A. (2008). Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. Lupus 17: 105-113 [Abstract]  
• Lee, S-S., Singh, S., Magder, L., Petri, M. (2008). Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17: 114-123 [Abstract]  
• Ridker, P. M, Chasman, D. I., Zee, R. Y.L., Parker, A., Rose, L., Cook, N. R., Buring, J. E, for the Women's Genome Health Study Working Group, (2008). Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women. Clin. Chem. 54: 249-255 [Abstract] [Full Text]  
• Packard, R. R. S., Libby, P. (2008). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin. Chem. 54: 24-38 [Abstract] [Full Text]  
• Zee, R. Y.L., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., Ridker, P. M (2007). Intercellular Adhesion Molecule 1 (ICAM1) Lys56Met and Gly241Arg Gene Variants, Plasma-Soluble ICAM1 Concentrations, and Risk of Incident Cardiovascular Events in 23 014 Initially Healthy White Women. Stroke 38: 3152-3157 [Abstract] [Full Text]  
• Vaccarino, V., Johnson, B. D., Sheps, D. S., Reis, S. E., Kelsey, S. F., Bittner, V., Rutledge, T., Shaw, L. J., Sopko, G., Bairey Merz, C. N. (2007). Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia: The National Heart, Lung, and Blood Institute Sponsored WISE Study. J Am Coll Cardiol 50: 2044-2050 [Abstract] [Full Text]  
• Novaro, G. M., Katz, R., Aviles, R. J., Gottdiener, J. S., Cushman, M., Psaty, B. M., Otto, C. M., Griffin, B. P. (2007). Clinical Factors, But Not C-Reactive Protein, Predict Progression of Calcific Aortic-Valve Disease: The Cardiovascular Health Study. J Am Coll Cardiol 50: 1992-1998 [Abstract] [Full Text]  
• Szwast, S. J., Hendrie, H. C., Lane, K. A., Gao, S., Taylor, S. E., Unverzagt, F., Murrell, J., Deeg, M., Ogunniyi, A., Farlow, M. R., Hall, K. S. (2007). Association of statin use with cognitive decline in elderly African Americans. Neurology 69: 1873-1880 [Abstract] [Full Text]  
• Grootendorst, D. C., de Jager, D. J., Brandenburg, V. M., Boeschoten, E. W., Krediet, R. T., Dekker, F. W., The NECOSAD Study Group, (2007). Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 22: 3277-3284 [Abstract] [Full Text]  
• Mullenix, P. S., Steele, S. R., Martin, M. J., Starnes, B. W., Andersen, C. A. (2007). C-reactive Protein Level and Traditional Vascular Risk Factors in the Prediction of Carotid Stenosis. Arch Surg 142: 1066-1071 [Abstract] [Full Text]  
• Spagnoli, L. G., Bonanno, E., Sangiorgi, G., Mauriello, A. (2007). Role of Inflammation in Atherosclerosis. JNM 48: 1800-1815 [Abstract] [Full Text]  
• Blumenthal, J. A, Sherwood, A., Rogers, S. D., Babyak, M. A., Murali Doraiswamy, P., Watkins, L., Hoffman, B. M., O'Connell, C., Johnson, J. J., Patidar, S. M., Waugh, R., Hinderliter, A. (2007). Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study rationale, design, and methodological issues. Clin Trials 4: 548-559 [Abstract]  
• Gortney, J. S., Sanders, R. M. (2007). Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health Syst Pharm 64: 2009-2016 [Abstract] [Full Text]  
• Memoli, B., Procino, A., Calabro, P., Esposito, P., Grandaliano, G., Pertosa, G., Prete, M. D., Andreucci, M., Lillo, S. D., Ferulano, G., Cillo, C., Savastano, S., Colao, A., Guida, B. (2007). Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am. J. Physiol. Endocrinol. Metab. 293: E1030-E1035 [Abstract] [Full Text]  
• Grisar, J., Aletaha, D., Steiner, C. W, Kapral, T., Steiner, S., Saemann, M., Schwarzinger, I., Buranyi, B., Steiner, G., Smolen, J. S (2007). Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis 66: 1284-1288 [Abstract] [Full Text]  
• Decensi, A., Gandini, S., Serrano, D., Cazzaniga, M., Pizzamiglio, M., Maffini, F., Pelosi, G., Daldoss, C., Omodei, U., Johansson, H., Macis, D., Lazzeroni, M., Penotti, M., Sironi, L., Moroni, S., Bianco, V., Rondanina, G., Gjerde, J., Guerrieri-Gonzaga, A., Bonanni, B. (2007). Randomized Dose-Ranging Trial of Tamoxifen at Low Doses in Hormone Replacement Therapy Users. JCO 25: 4201-4209 [Abstract] [Full Text]  
• Hage, F. G., Szalai, A. J. (2007). C-Reactive Protein Gene Polymorphisms, C-Reactive Protein Blood Levels, and Cardiovascular Disease Risk. J Am Coll Cardiol 50: 1115-1122 [Abstract] [Full Text]  
• Finkelstein, F. O., West, W., Gobin, J., Finkelstein, S. H., Wuerth, D. (2007). Spirituality, quality of life and the dialysis patient. Nephrol Dial Transplant 22: 2432-2434 [Full Text]  
• Kalantar-Zadeh, K. (2007). Inflammatory Marker Mania in Chronic Kidney Disease: Pentraxins at the Crossroad of Universal Soldiers of Inflammation. CJASN 2: 872-875 [Full Text]  
• Park, D.-W., Lee, C. W., Yun, S.-C., Kim, Y.-H., Hong, M.-K., Kim, J.-J., Park, S.-W., Park, S.-J. (2007). Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation. Heart 93: 1087-1092 [Abstract] [Full Text]  
• Teoh, H., Quan, A., Verma, S. (2007). Does C-reactive protein predict saphenous vein graft patency?. J. Thorac. Cardiovasc. Surg. 134: 277-279 [Full Text]  
• Momin, A., Melikian, N., Wheatcroft, S. B., Grieve, D., John, L. C., El Gamel, A., Marrinan, M. T., Desai, J. B., Driver, C., Sherwood, R., Shah, A. M., Kearney, M. T. (2007). The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 134: 335-341 [Abstract] [Full Text]  
• Sesso, H. D., Gaziano, J. M., Jenkins, D. J.A., Buring, J. E. (2007). Strawberry Intake, Lipids, C-Reactive Protein, and the Risk of Cardiovascular Disease in Women. J. Am. Coll. Nutr. 26: 303-310 [Abstract] [Full Text]  
• Lawson, E. A., Miller, K. K., Mathur, V. A., Misra, M., Meenaghan, E., Herzog, D. B., Klibanski, A. (2007). Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women. J. Clin. Endocrinol. Metab. 92: 3089-3094 [Abstract] [Full Text]  
• Tousoulis, D., Antoniades, C., Stefanadis, C. (2007). Assessing inflammatory status in cardiovascular disease. Heart 93: 1001-1007 [Full Text]  
• Stockley, R A (2007). Biomarkers in COPD: time for a deep breath. Thorax 62: 657-660 [Full Text]  
• O'Neill, S. G, Isenberg, D. A, Rahman, A. (2007). Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?. Ann Rheum Dis 66: 989-991 [Full Text]  
• Motoyama, S., Kondo, T., Sarai, M., Sugiura, A., Harigaya, H., Sato, T., Inoue, K., Okumura, M., Ishii, J., Anno, H., Virmani, R., Ozaki, Y., Hishida, H., Narula, J. (2007). Multislice Computed Tomographic Characteristics of Coronary Lesions in Acute Coronary Syndromes. J Am Coll Cardiol 50: 319-326 [Abstract] [Full Text]  
• Gozal, D., Crabtree, V. M., Sans Capdevila, O., Witcher, L. A., Kheirandish-Gozal, L. (2007). C-reactive Protein, Obstructive Sleep Apnea, and Cognitive Dysfunction in School-aged Children. Am. J. Respir. Crit. Care Med. 176: 188-193 [Abstract] [Full Text]  
• Miller, K. K., Biller, B. M. K., Schaub, A., Pulaski-Liebert, K., Bradwin, G., Rifai, N., Klibanski, A. (2007). Effects of Testosterone Therapy on Cardiovascular Risk Markers in Androgen-Deficient Women with Hypopituitarism. J. Clin. Endocrinol. Metab. 92: 2474-2479 [Abstract] [Full Text]  
• Crimmins, E. M., Kim, J. K., Alley, D. E., Karlamangla, A., Seeman, T. (2007). Hispanic Paradox in Biological Risk Profiles. Am. J. Public Health 97: 1305-1310 [Abstract] [Full Text]  
• Rohde, E., Bartmann, C., Schallmoser, K., Reinisch, A., Lanzer, G., Linkesch, W., Guelly, C., Strunk, D. (2007). Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro. Stem Cells 25: 1746-1752 [Abstract] [Full Text]  
• Zhang, S. M., Lin, J., Cook, N. R., Lee, I-M., Manson, J. E., Buring, J. E., Ridker, P. M. (2007). C-Reactive Protein and Risk of Breast Cancer. JNCI J Natl Cancer Inst 99: 890-894 [Abstract] [Full Text]  
• Thambidorai, S. K., Jaffer, S. J., Shah, T. K., Stewart, W. J., Klein, A. L., Lauer, M. S. (2007). Association of atheroma as assessed by intraoperative transoesophageal echocardiography with long-term mortality in patients undergoing cardiac surgery. Eur Heart J 0: ehm180v1-8 [Abstract] [Full Text]  
• Celli, B. R., Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238 [Abstract] [Full Text]  
• ABOU-RAYA, S., ABOU-RAYA, A., NAIM, A., ABUELKHEIR, H. (2007). Chronic Inflammatory Autoimmune Disorders and Atherosclerosis. Ann. N. Y. Acad. Sci. 1107: 56-67 [Abstract] [Full Text]  
• Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C., Hildebrandt, P. R. (2007). N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 28: 1374-1381 [Abstract] [Full Text]  
• Ridker, P. M. (2007). C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus. J Am Coll Cardiol 49: 2129-2138 [Abstract] [Full Text]  
• Szmitko, P. E., Verma, S. (2007). C-Reactive Protein and Reendothelialization: NO Involvement. Circ. Res. 100: 1405-1407 [Full Text]  
• Schwartz, R., Osborne-Lawrence, S., Hahner, L., Gibson, L. L., Gormley, A. K., Vongpatanasin, W., Zhu, W., Word, R. A., Seetharam, D., Black, S., Samols, D., Mineo, C., Shaul, P. W. (2007). C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in Mice. Circ. Res. 100: 1452-1459 [Abstract] [Full Text]  
• Ridker, P. M, Everett, B. M. (2007). Letter by Ridker and Everett Regarding Article, "The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?". Circulation 115: e475-e475 [Full Text]  
• Steinhubl, S. R., Badimon, J. J., Bhatt, D. L., Herbert, J.-M., Luscher, T. F. (2007). Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 12: 113-122 [Abstract]  
• Mallat, Z., Benessiano, J., Simon, T., Ederhy, S., Sebella-Arguelles, C., Cohen, A., Huart, V., Wareham, N. J., Luben, R., Khaw, K.-T., Tedgui, A., Boekholdt, S. M. (2007). Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women: The EPIC-NORFOLK Study. Arterioscler. Thromb. Vasc. Bio. 27: 1177-1183 [Abstract] [Full Text]  
• Zee, R. Y.L., Mora, S., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., Ridker, P. M (2007). Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women. Clin. Chem. 53: 845-851 [Abstract] [Full Text]  
• Miller, D. T., Ridker, P. M., Libby, P., Kwiatkowski, D. J. (2007). Atherosclerosis: The Path From Genomics to Therapeutics. J Am Coll Cardiol 49: 1589-1599 [Abstract] [Full Text]  
• Bisoendial, R. J., Kastelein, J. J. P., Peters, S. L. M., Levels, J. H. M., Birjmohun, R., Rotmans, J. I., Hartman, D., Meijers, J. C. M., Levi, M., Stroes, E. S. G. (2007). Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J. Lipid Res. 48: 952-960 [Abstract] [Full Text]  
• Vigorito, C., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Lucci, R., De Lorenzo, A., Tafuri, D., Lombardi, G., Colao, A., Orio, F. (2007). Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 92: 1379-1384 [Abstract] [Full Text]  
• Schlager, O., Exner, M., Mlekusch, W., Sabeti, S., Amighi, J., Dick, P., Wagner, O., Koppensteiner, R., Minar, E., Schillinger, M. (2007). C-Reactive Protein Predicts Future Cardiovascular Events in Patients With Carotid Stenosis. Stroke 38: 1263-1268 [Abstract] [Full Text]  
• Shu, W., Lei, W., Peng, S. (2007). Recent development of ischaemic heart disease in sex difference. Postgrad. Med. J. 83: 240-243 [Abstract] [Full Text]  
• King, D. E., Egan, B. M., Woolson, R. F., Mainous, A. G. III, Al-Solaiman, Y., Jesri, A. (2007). Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level. Arch Intern Med 167: 502-506 [Abstract] [Full Text]  
• Revkin, J. H., Shear, C. L., Pouleur, H. G., Ryder, S. W., Orloff, D. G. (2007). Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future. Pharmacol. Rev. 59: 40-53 [Abstract] [Full Text]  
• Schaumberg, D. A., Christen, W. G., Buring, J. E., Glynn, R. J., Rifai, N., Ridker, P. M. (2007). High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women. Arch Ophthalmol 125: 300-305 [Abstract] [Full Text]  
• Ishikawa, J., Tamura, Y., Hoshide, S., Eguchi, K., Ishikawa, S., Shimada, K., Kario, K. (2007). Low-Grade Inflammation Is a Risk Factor for Clinical Stroke Events in Addition to Silent Cerebral Infarcts in Japanese Older Hypertensives: The Jichi Medical School ABPM Study, Wave 1. Stroke 38: 911-917 [Abstract] [Full Text]  
• Deutsch, L. (2007). Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms. J. Am. Coll. Nutr. 26: 39-48 [Abstract] [Full Text]  
• Banaszewska, B., Pawelczyk, L., Spaczynski, R. Z., Dziura, J., Duleba, A. J. (2007). Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial. J. Clin. Endocrinol. Metab. 92: 456-461 [Abstract] [Full Text]  
• Belay, B., Belamarich, P. F., Tom-Revzon, C. (2007). The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions. Pediatrics 119: 370-380 [Abstract] [Full Text]  
• Anwaruddin, S., Askari, A. T., Topol, E. J. (2007). Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine. J Am Coll Cardiol 49: 279-289 [Abstract] [Full Text]  
• Capuzzi, D. M., Freeman, J. S. (2007). C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge. Clin. Diabetes 25: 16-22 [Abstract] [Full Text]  
• Kusminski, C. M., da Silva, N. F., Creely, S. J., Fisher, F. M., Harte, A. L., Baker, A. R., Kumar, S., McTernan, P. G. (2007). The in Vitro Effects of Resistin on the Innate Immune Signaling Pathway in Isolated Human Subcutaneous Adipocytes. J. Clin. Endocrinol. Metab. 92: 270-276 [Abstract] [Full Text]  
• Ji, S.-R., Wu, Y., Zhu, L., Potempa, L. A., Sheng, F.-L., Lu, W., Zhao, J. (2007). Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm. FASEB J. 21: 284-294 [Abstract] [Full Text]  
• Inoue, K., Sugiyama, A., Reid, P. C., Ito, Y., Miyauchi, K., Mukai, S., Sagara, M., Miyamoto, K., Satoh, H., Kohno, I., Kurata, T., Ota, H., Mantovani, A., Hamakubo, T., Daida, H., Kodama, T. (2007). Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris. Arterioscler. Thromb. Vasc. Bio. 27: 161-167 [Abstract] [Full Text]  
• Gross, M.-L., Meyer, H.-P., Ziebart, H., Rieger, P., Wenzel, U., Amann, K., Berger, I., Adamczak, M., Schirmacher, P., Ritz, E. (2007). Calcification of Coronary Intima and Media: Immunohistochemistry, Backscatter Imaging, and X-Ray Analysis in Renal and Nonrenal Patients. CJASN 2: 121-134 [Abstract] [Full Text]  
• Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., Benjamin, E. J., D'Agostino, R. B., Vasan, R. S. (2006). Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death. NEJM 355: 2631-2639 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Rodriguez-Yanez, M., Castellanos, M., Blanco, M., Garcia, M. M., Nombela, F., Serena, J., Leira, R., Lizasoain, I., Davalos, A., Castillo, J. (2006). New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology 67: 1973-1978 [Abstract] [Full Text]  
• Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M. (2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol 48: 2235-2242 [Abstract] [Full Text]  
• MITRAKOU, A. (2006). Women's Health and the Metabolic Syndrome. Ann. N. Y. Acad. Sci. 1092: 33-48 [Abstract] [Full Text]  
• Cappabianca, G., Paparella, D., Visicchio, G., Capone, G., Lionetti, G., Numis, F., Ferrara, P., D'Agostino, C., de Luca Tupputi Schinosa, L. (2006). Preoperative C-Reactive Protein Predicts Mid-Term Outcome After Cardiac Surgery. Ann. Thorac. Surg. 82: 2170-2178 [Abstract] [Full Text]  
• Van de Veire, N R, Philippe, J, De Winter, O, Langlois, M, Bernard, D, De Sutter, J (2006). Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins.. Heart 92: 1858-1859 [Full Text]  
• Lawler, J. M., Kwak, H.-B., Song, W., Parker, J. L. (2006). Exercise training reverses downregulation of HSP70 and antioxidant enzymes in porcine skeletal muscle after chronic coronary artery occlusion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R1756-R1763 [Abstract] [Full Text]  
• Kishimoto, C. (2006). A Novel Approach to the Suppression of Atherosclerosis by Fc{gamma} Receptor Blockade.. Circ. Res. 99: 1154-1155 [Full Text]